{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:22:56Z","timestamp":1790688176710,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,11,17]],"date-time":"2013-11-17T00:00:00Z","timestamp":1384646400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s10552-013-0320-z","type":"journal-article","created":{"date-parts":[[2013,11,16]],"date-time":"2013-11-16T00:15:34Z","timestamp":1384560934000},"page":"179-189","source":"Crossref","is-referenced-by-count":62,"title":["Carcinogenic HPV prevalence and age-specific type distribution in 40,382 women with normal cervical cytology, ASCUS\/LSIL, HSIL, or cervical cancer: what is the potential for prevention?"],"prefix":"10.1007","volume":"25","author":[{"given":"Susanne K.","family":"Kj\u00e6r","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Munk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jette","family":"Junge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Iftner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,11,17]]},"reference":[{"issue":"12","key":"320_CR1","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","volume":"127","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893\u20132917. doi: 10.1002\/ijc.25516","journal-title":"Int J Cancer"},{"issue":"Suppl 3","key":"320_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vaccine.2006.05.115","volume":"24","author":"N Mu\u00f1oz","year":"2006","unstructured":"Mu\u00f1oz N, Castellsagu\u00e9 X, de Gonz\u00e1les AB, Gissman L (2006) Chapter 1. HPV in the etiology of human cancer. Vaccine 24(Suppl 3):1\u201310","journal-title":"Vaccine"},{"key":"320_CR3","unstructured":"NORDCAN ( http:\/\/www.ancr.nu\/default_old.asp ) updated Oct. 2009"},{"issue":"1","key":"320_CR4","doi-asserted-by":"crossref","first-page":"33.e1\u20136","DOI":"10.1016\/j.ajog.2009.02.004","volume":"201","author":"B Noehr","year":"2009","unstructured":"Noehr B, Jensen A, Frederiksen K, Tabor A, Kjaer SK (2009) Loop electrosurgical excision of the cervix and subsequent risk for spontaneous preterm delivery: a population-based study of singleton deliveries during a 9-year period. Am J Obstet Gynecol 201(1):33.e1\u20136. doi: 10.1016\/j.ajog.2009.02.004","journal-title":"Am J Obstet Gynecol"},{"key":"320_CR5","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0140-6736(06)68439-0","volume":"367","author":"DM Harper","year":"2006","unstructured":"Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romonowski B, Roteli-Martins CM et al (2006) Sustained efficacy up to 4\u20135\u00a0years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet 367:1247\u20131255","journal-title":"Lancet"},{"issue":"10","key":"320_CR6","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1158\/1940-6207.CAPR-09-0031","volume":"2","author":"SK Kjaer","year":"2009","unstructured":"Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G et al (2009) A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6\/11\/16\/18) vaccine against high-grade cervical and external genital lesions. Cancer Prev Res (Phila) 2(10):868\u2013878. doi: 10.1158\/1940-6207.CAPR-09-0031","journal-title":"Cancer Prev Res (Phila)"},{"issue":"7","key":"320_CR7","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nrclinonc.2013.84","volume":"10","author":"M Lehtinen","year":"2013","unstructured":"Lehtinen M, Dillner J (2013) Clinical trials of human papillomavirus vaccines and beyond. Nat Rev Clin Oncol 10(7):400\u2013410. doi: 10.1038\/nrclinonc.2013.84","journal-title":"Nat Rev Clin Oncol"},{"issue":"19","key":"320_CR8","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","volume":"356","author":"SM Garland","year":"2007","unstructured":"Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S et al (2007) Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 356(19):1928\u20131943","journal-title":"N Engl J Med"},{"issue":"9574","key":"320_CR9","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0140-6736(07)60777-6","volume":"369","author":"EA Joura","year":"2007","unstructured":"Joura EA, Leodolter S, Hernandez-Avila M, Wheeler CM, Perez G, Koutsky LA et al (2007) Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) virus-like particle vaccine against high-grade vulvar and vaginal lesions: a combined analysis of three randomised clinical trials. Lancet 369(9574):1693\u20131702","journal-title":"Lancet"},{"issue":"3","key":"320_CR10","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/OLQ.0b013e31815ac5c7","volume":"35","author":"A Nielsen","year":"2008","unstructured":"Nielsen A, Kjaer SK, Munk C, Iftner T (2008) Type-specific HPV infection and multiple HPV types: prevalence and risk factor profile in nearly 12,000 younger and older Danish women. Sex Transm Dis 35(3):276\u2013282","journal-title":"Sex Transm Dis"},{"issue":"8","key":"320_CR11","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1002\/ijc.23712","volume":"123","author":"SK Kj\u00e6r","year":"2008","unstructured":"Kj\u00e6r SK, Breugelmans G, Munk C, Junge J, Watson M, Iftner T (2008) Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark. Int J Cancer 123(8):1864\u20131870","journal-title":"Int J Cancer"},{"issue":"8","key":"320_CR12","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1136\/sextrans-2011-050307","volume":"88","author":"A Nielsen","year":"2012","unstructured":"Nielsen A, Iftner T, N\u00f8rgaard M, Munk C, Junge J, Kjaer SK (2012) The importance of low-risk HPV infection for the risk of abnormal cervical cytology\/histology in more than 40 000 Danish women. Sex Transm Infect 88(8):627\u2013632. doi: 10.1136\/sextrans-2011-050307","journal-title":"Sex Transm Infect"},{"issue":"7","key":"320_CR13","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1086\/597307","volume":"199","author":"DR Brown","year":"2009","unstructured":"Brown DR, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM et al (2009) The impact of quadrivalent hpv (type 6\/11\/16\/18) L1 VLP vaccine on infection and disease due to Oncogenic non-vaccine HPV types in generally HPV naive women aged 16\u201326. J Infect Dis 199(7):926\u2013935","journal-title":"J Infect Dis"},{"issue":"7","key":"320_CR14","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1086\/597309","volume":"199","author":"CM Wheeler","year":"2009","unstructured":"Wheeler CM, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Perez G (2009) The impact of quadrivalent HPV (types 6\/11\/16\/18) L1 vlp vaccine on infection and disease due to oncogenic non-vaccine hpv types in sexually active women aged 16\u201326. J Infect Dis 199(7):936\u2013944","journal-title":"J Infect Dis"},{"issue":"10","key":"320_CR15","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1473-3099(12)70187-1","volume":"12","author":"T Malagon","year":"2012","unstructured":"Malagon T, Drolet M, Boily MC, Franco EL, Jit M, Brisson J, Brisson M (2012) Crossprotective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis. Lancet Infect Dis 12(10):781\u2013789","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"320_CR16","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1080\/j.1600-0412.1998.770908.x","volume":"77","author":"C Munk","year":"1998","unstructured":"Munk C, Kjaer SK, Poll P, Bock JE (1998) Cervical cancer screening: knowledge of own screening status among women aged 20\u201329\u00a0years. Acta Obstet Gynecol Scand 77(9):917\u2013922","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"Suppl 7","key":"320_CR17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1403494810387965","volume":"39","author":"CB Pedersen","year":"2011","unstructured":"Pedersen CB (2011) The Danish civil registration system. Scand J Public Health 39(Suppl 7):22\u201325","journal-title":"Scand J Public Health"},{"issue":"Suppl 7","key":"320_CR18","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1177\/1403494810393563","volume":"39","author":"B Bjerregaard","year":"2011","unstructured":"Bjerregaard B, Larsen OB (2011) The Danish pathology register. Scand J Public Health 39(Suppl 7):72\u201374","journal-title":"Scand J Public Health"},{"issue":"12","key":"320_CR19","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1086\/657321","volume":"202","author":"L Bruni","year":"2010","unstructured":"Bruni L, Diaz M, Castellsagu\u00e9 X, Ferrer E, Bosch FX, de Sanjos\u00e9 S (2010) Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis 202(12):1789\u20131799. doi: 10.1086\/657321","journal-title":"J Infect Dis"},{"issue":"5","key":"320_CR20","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1600-0412.2010.01066.x","volume":"90","author":"KE Jensen","year":"2011","unstructured":"Jensen KE, Munk C, Sparen P, Tryggvadottir L, Liaw KL, Dasbach E, Nyg\u00e5rd M, Kjaer SK (2011) Women\u2019s sexual behavior. Population-based study among 65,000 women from four Nordic countries before introduction of human papillomavirus vaccination. Acta Obstet Gynecol Scand 90(5):459\u2013467. doi: 10.1111\/j.1600-0412.2010.01066.x","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"4","key":"320_CR21","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/jmv.21750","volume":"82","author":"A Nielsen","year":"2010","unstructured":"Nielsen A, Kjaer SK, Munk C, Osler M, Iftner T (2010) Persistence of high-risk human papillomavirus infection in a population-based cohort of Danish women. J Med Virol 82(4):616\u2013623. doi: 10.1002\/jmv.21750","journal-title":"J Med Virol"},{"issue":"4","key":"320_CR22","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1158\/1055-9965.EPI-10-1108","volume":"20","author":"RL Winer","year":"2011","unstructured":"Winer RL, Hughes JP, Feng Q, Xi LF, Cherne S, O\u2019Reilly S, Kiviat NB, Koutsky LA (2011) Early natural history of incident, type-specific human papillomavirus infections in newly sexually active young women. Cancer Epidemiol Biomarkers Prev 20(4):699\u2013707","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"320_CR23","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1476-9255-4-8","volume":"4","author":"JA Passmore","year":"2007","unstructured":"Passmore JA, Morroni C, Shapiro S, Williamson AL, Hoffman M (2007) Papanicolaou smears and cervical inflammatory cytokine responses. J Inflamm (Lond) 4:8","journal-title":"J Inflamm (Lond)"},{"issue":"4","key":"320_CR24","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1582-4934.2008.00631.x","volume":"13","author":"M Arbyn","year":"2009","unstructured":"Arbyn M, Martin-Hirsch P, Buntinx F, Van Ranst M, Paraskevaidis E, Dillner J (2009) Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate. J Cell Mol Med 13(4):648\u2013659. doi: 10.1111\/j.1582-4934.2008.00631.x","journal-title":"J Cell Mol Med"},{"issue":"1","key":"320_CR25","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1158\/1055-9965.EPI-08-0510","volume":"18","author":"M Arbyn","year":"2009","unstructured":"Arbyn M, Benoy I, Simoens C, Bogers J, Beutels P, Depuydt C (2009) Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium. Cancer Epidemiol Biomarkers Prev 18(1):321\u2013330. doi: 10.1158\/1055-9965.EPI-08-0510","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"10","key":"320_CR26","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1038\/sj.bjc.6604324","volume":"98","author":"A Sargent","year":"2008","unstructured":"Sargent A, Bailey A, Almonte M, Turner A, Thomson C, Peto J, Desai M, Mather J, Moss S, Roberts C, Kitchener HC, ARTISTIC Study Group (2008) Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial. Br J Cancer 98(10):1704\u20131709. doi: 10.1038\/sj.bjc.6604324","journal-title":"Br J Cancer"},{"issue":"19","key":"320_CR27","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1093\/jnci\/djq356","volume":"102","author":"SK Kj\u00e6r","year":"2010","unstructured":"Kj\u00e6r SK, Frederiksen K, Munk C, Iftner T (2010) Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence. J Natl Cancer Inst 102(19):1478\u20131488. doi: 10.1093\/jnci\/djq356","journal-title":"J Natl Cancer Inst"},{"key":"320_CR28","doi-asserted-by":"crossref","first-page":"a1754","DOI":"10.1136\/bmj.a1754","volume":"337","author":"J Dillner","year":"2008","unstructured":"Dillner J, Rebolj M, Birembaut P, Petry KU, Szarewski A, Munk C, de Sanjose S, Naucler P, Lloveras B, Kjaer S, Cuzick J, van Ballegooijen M, Clavel C, Iftner T (2008) Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. BMJ 337:a1754","journal-title":"BMJ"},{"issue":"21","key":"320_CR29","doi-asserted-by":"crossref","first-page":"10630","DOI":"10.1158\/0008-5472.CAN-06-1057","volume":"66","author":"S Kjaer","year":"2006","unstructured":"Kjaer S, H\u00f8gdall E, Frederiksen K, Munk C, van den Brule A, Svare E, Meijer C, Lorincz A, Iftner T (2006) The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period. Cancer Res 66(21):10630\u201310636","journal-title":"Cancer Res"},{"issue":"5","key":"320_CR30","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/jnci\/djj067","volume":"98","author":"X Castellsagu\u00e9","year":"2006","unstructured":"Castellsagu\u00e9 X, D\u00edaz M, de Sanjos\u00e9 S, Mu\u00f1oz N, Herrero R, Franceschi S, Peeling RW, Ashley R, Smith JS, Snijders PJ, Meijer CJ, Bosch FX, International Agency for Research on Cancer Multicenter Cervical Cancer Study Group (2006) Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst 98(5):303\u2013315","journal-title":"J Natl Cancer Inst"},{"key":"320_CR31","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1086\/428850","volume":"191","author":"R Herrero","year":"2005","unstructured":"Herrero R, Castle PE, Schiffman M, Bratti MC, Hildesheim A, Morales J et al (2005) Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis 191:1796\u20131807","journal-title":"J Infect Dis"},{"key":"320_CR32","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1158\/1055-9965.EPI-10-0251","volume":"19","author":"PE Castle","year":"2010","unstructured":"Castle PE, Schiffman M, Wheeler CM, Wentzensen N, Gravitt PE (2010) Human papillomavirus genotypes in cervical intraepithelial neoplasia grade 3. Cancer Epidemiol Biomarkers Prev 19:1675\u20131681","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"320_CR33","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1158\/1055-9965.EPI-10-1267","volume":"20","author":"PE Castle","year":"2011","unstructured":"Castle PE, Shaber R, Lamere B, Kinney W, Fetterman B, Poitras N et al (2011) Human papillomavirus (HPV) genotypes in women with cervical precancer and cancer at Kaiser Permanente Northern California. Cancer Epidemiol Biomarkers Prev 20:946\u2013953","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"320_CR34","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ygyno.2011.10.020","volume":"124","author":"L Baandrup","year":"2012","unstructured":"Baandrup L, Munk C, Andersen KK, Junge J, Iftner T, Kj\u00e6r SK (2012) HPV16 is associated with younger age in women with cervical intraepithelial neoplasia grade 2 and 3. Gynecol Oncol 124(2):281\u2013285. doi: 10.1016\/j.ygyno.2011.10.020","journal-title":"Gynecol Oncol"},{"issue":"7","key":"320_CR35","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/cid\/cit436","volume":"57","author":"M Blomberg","year":"2013","unstructured":"Blomberg M, Dehlendorff C, Munk C, Kjaer SK (2013) Strongly decreased risk of genital warts after vaccination against human papillomavirus: nationwide follow-up of vaccinated and unvaccinated girls in Denmark. Clin Infect Dis 57(7):929\u2013934. doi: 10.1093\/cid\/cit436","journal-title":"Clin Infect Dis"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-013-0320-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-013-0320-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-013-0320-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T13:06:30Z","timestamp":1559221590000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-013-0320-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,17]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["320"],"URL":"https:\/\/doi.org\/10.1007\/s10552-013-0320-z","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,17]]}}}